Neuropsychological test battery in the follow-up of patients with juvenile neuronal ceroid lipofuscinosis.
暂无分享,去创建一个
T. Autti | L. Åberg | J. Kaukoranta | S. Lamminranta | P. Santavuori | T. Laine | R. Morén
[1] N. Viukari. Intolerance to diphenylhydantoin in five cases of Vogt-Spielmeyer disease. , 2008, Journal of mental deficiency research.
[2] M. Hämäläinen,et al. Sleep alterations in juvenile neuronal ceroid-lipofuscinosis. , 2000, Pediatric neurology.
[3] T. Autti,et al. Clinical and magnetic resonance imaging findings in batten disease: Analysis of the major mutation (1.02‐kb deletion) , 1997, Annals of neurology.
[4] P. Munroe,et al. Rapid diagnostic test for the major mutation underlying Batten disease. , 1996, Journal of medical genetics.
[5] R. Kuzniecky,et al. Qualitative MRI Segmentation in Mesial Temporal Sclerosis: Clinical Correlations , 1996, Epilepsia.
[6] P. Munroe,et al. Prenatal diagnosis of Batten's disease , 1996, The Lancet.
[7] H. Heiskala,et al. Brain perfusion SPECT in juvenile neuronal ceroid lipofuscinosis. , 1996, Neuropediatrics.
[8] R. Kuzniecky. Neuroimaging in Pediatric Epilepsy , 1996, Epilepsia.
[9] A. Shah,et al. Free radicals, anticonvulsants, and the neuronal ceroid-lipofuscinoses. , 1995, American journal of medical genetics.
[10] C. Messa,et al. Spielmeyer-Vogt (Batten, Spielmeyer-Sjögren) disease. Distinctive patterns of cerebral glucose utilization. , 1994, Brain : a journal of neurology.
[11] L. Peltonen,et al. Batten disease (Spielmeyer-Vogt disease, juvenile onset neuronal ceroid-lipofuscinosis) gene (CLN3) maps to human chromosome 16. , 1990, Genomics.
[12] P. Santavuori,et al. Neuronal ceroid-lipofuscinoses in childhood , 1988, Brain and Development.
[13] P. Santavuori,et al. Experience of antioxidant treatment in neuronal ceroid-lipofuscinosis of Spielmeyer-Sjögren type. , 1977, Neuropadiatrie.
[14] H. Lou,et al. A Clinical and Psychological Investigation into Juvenile Amaurotic Idiocy in Denmark , 1973, Developmental medicine and child neurology.
[15] J. Opitz,et al. Experience over 17 years with antioxidant treatment in Spielmeyer-Sjögren disease. , 1988, American journal of medical genetics. Supplement.
[16] J. Westlake,et al. C-band polymorphism: comparison between trisomy 21 cases and mentally retarded controls. , 1980, American journal of medical genetics.